ATPase activity required for termination of transcription by the Escherichia coli protein factor rho.

PubWeight™: 1.45‹?› | Rank: Top 5%

🔗 View Article (PMID 131127)

Published in J Biol Chem on April 25, 1976

Authors

B H Howard, B de Crombrugghe

Articles citing this

Isolation and characterization of conditional lethal mutants of Escherichia coli defective in transcription termination factor rho. Proc Natl Acad Sci U S A (1976) 4.93

Structure of rho factor: an RNA-binding domain and a separate region with strong similarity to proven ATP-binding domains. Proc Natl Acad Sci U S A (1988) 1.58

Multiple roles for ATP in the synthesis and processing of mRNA by vaccinia virus: specific inhibitory effects of adenosine (beta,gamma-imido) triphosphate. J Virol (1978) 1.53

Transcription in vitro of bacteriophage lambda 4S RNA: studies on termination and rho protein. Nucleic Acids Res (1977) 1.33

Interaction of RNA polymerase and rho in transcription termination: coupled ATPase. Proc Natl Acad Sci U S A (1978) 1.33

Termination of transcription by Escherichia coli RNA polymerase: influence of secondary structure of RNA transcripts on rho-independent and rho-dependent termination. Proc Natl Acad Sci U S A (1979) 1.29

Polarity effects in the hisG gene of salmonella require a site within the coding sequence. Genetics (1988) 1.26

rho is not essential for viability or virulence in Staphylococcus aureus. Antimicrob Agents Chemother (2001) 1.19

The attenuator of the tryptophan operon in E.coli: rho-mediated release of RNA polymerase from a transcription termination complex in vitro. Nucleic Acids Res (1978) 1.14

Studies of RNA release reaction catalyzed by E. coli transcription termination factor rho using isolated ternary transcription complexes. Nucleic Acids Res (1980) 1.12

Transcription termination defective mutants of Rho: role of different functions of Rho in releasing RNA from the elongation complex. J Mol Biol (2007) 1.11

Escherichia coli transcription termination factor rho has a two-domain structure in its activated form. Proc Natl Acad Sci U S A (1985) 0.95

Pyrophosphate inhibition of rho ATPase: a mechanism of coupling to RNA polymerase activity. Proc Natl Acad Sci U S A (1982) 0.92

Relation between UV suppression of polarity in phi X174 and UV sensitivity of rho mutants. J Virol (1981) 0.88

Conformational alterations of transcription termination protein rho induced by ATP and by RNA. Nucleic Acids Res (1984) 0.86

Escherichia coli Rho factor is involved in lysis of bacteriophage T4-infected cells. Genetics (1985) 0.82

A possible mechanism responsible for the correction of transcription errors. Nucleic Acids Res (1979) 0.81

Nucleoside Triphosphate Phosphohydrolase I (NPH I) Functions as a 5' to 3' Translocase in Transcription Termination of Vaccinia Early Genes. J Biol Chem (2016) 0.75

Mutations in the ATP-binding domain of Escherichia coli rho factor affect transcription termination in vivo. J Bacteriol (1990) 0.75

Articles by these authors

Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75

The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proc Natl Acad Sci U S A (1982) 20.55

Evidence for two functional gal promoters in intact Escherichia coli cells. J Biol Chem (1981) 17.42

The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell (1996) 16.57

A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature (1996) 10.81

Synthesis of rabbit beta-globin in cultured monkey kidney cells following infection with a SV40 beta-globin recombinant genome. Nature (1979) 9.99

Cyclic AMP receptor protein: role in transcription activation. Science (1984) 8.37

High efficiency DNA-mediated transformation of primate cells. Science (1983) 8.09

Sox9 is required for cartilage formation. Nat Genet (1999) 7.89

SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol (1997) 5.72

Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate. Nucleic Acids Res (1983) 5.61

Identification of a functional promoter in the long terminal repeat of Rous sarcoma virus. Cell (1980) 5.51

Dual control for transcription of the galactose operon by cyclic AMP and its receptor protein at two interspersed promoters. Cell (1977) 5.29

Histone-like TAFs within the PCAF histone acetylase complex. Cell (1998) 5.26

Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol (1987) 5.25

A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J (1998) 5.15

Structure of the promoter for chicken alpha 2 type I collagen gene. Proc Natl Acad Sci U S A (1981) 4.89

Enhanced gene expression by the poly(dT-dG).poly(dC-dA) sequence. Mol Cell Biol (1984) 4.44

Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem (1999) 4.38

Efficient expression of Escherichia coli galactokinase gene in mammalian cells. Proc Natl Acad Sci U S A (1982) 4.25

Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci U S A (2001) 4.13

The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell (2001) 4.11

Interaction site of Escherichia coli cyclic AMP receptor protein on DNA of galactose operon promoters. Proc Natl Acad Sci U S A (1979) 3.83

Levels of translatable mRNAs for cell surface protein, collagen precursors, and two membrane proteins are altered in Rous sarcoma virus-transformed chick embryo fibroblasts. Proc Natl Acad Sci U S A (1977) 3.80

A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta. Cell (1988) 3.72

The collagen gene: evidence for its evolutinary assembly by amplification of a DNA segment containing an exon of 54 bp. Cell (1980) 3.66

Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol Cell (1997) 3.54

A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells. J Biol Chem (1996) 3.30

Separate cis-acting DNA elements of the mouse pro-alpha 1(I) collagen promoter direct expression of reporter genes to different type I collagen-producing cells in transgenic mice. J Cell Biol (1995) 3.16

The family of collagen genes. Annu Rev Biochem (1990) 2.98

Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1. J Biol Chem (2000) 2.89

Role of the CCAAT-binding protein CBF/NF-Y in transcription. Trends Biochem Sci (1998) 2.71

Nucleotide sequence of the operator-promoter region of the galactose operon of Escherichia coli. Proc Natl Acad Sci U S A (1977) 2.57

DNA mutagenesis and recombination. Nature (1990) 2.45

Unusual methylation pattern of the alpha 2 (l) collagen gene. Cell (1982) 2.36

Unusual location and function of the operator in the Escherichia coli galactose operon. Nature (1979) 2.35

Mutations in the Escherichia coli operon that define two promoters and the binding site of the cyclic AMP receptor protein. J Mol Biol (1982) 2.30

Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J Biol Chem (1998) 2.26

Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J Biol Chem (1998) 2.21

Isolation and characterization of overlapping genomic clones covering the chicken alpha 2 (type I) collagen gene. Proc Natl Acad Sci U S A (1980) 2.18

Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3. Proc Natl Acad Sci U S A (1995) 2.17

Selective activation of transcription by a novel CCAAT binding factor. Science (1988) 2.12

Use of recombinant plasmids to characterize collagen RNAs in normal and transformed chick embryo fibroblasts. J Biol Chem (1979) 2.07

Identification of a cell-specific transcriptional enhancer in the first intron of the mouse alpha 2 (type I) collagen gene. Proc Natl Acad Sci U S A (1987) 2.07

Correlation between splicing sites within an intron and their sequence complementarity with U1 RNA. Cell (1980) 2.02

Transforming growth factor beta: biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis. Recent Prog Horm Res (1988) 1.99

Transcriptional activation encoded by the v-fos gene. Proc Natl Acad Sci U S A (1986) 1.99

L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthritis Cartilage (2001) 1.96

A rapid method for recombination and site-specific mutagenesis by placing homologous ends on DNA using polymerase chain reaction. Biotechniques (1991) 1.93

A CCAAT DNA binding factor consisting of two different components that are both required for DNA binding. J Biol Chem (1988) 1.93

A 182 bp fragment of the mouse pro alpha 1(II) collagen gene is sufficient to direct chondrocyte expression in transgenic mice. J Cell Sci (1995) 1.90

Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-alpha. J Biol Chem (2000) 1.86

Regulation of a collagen gene promoter by the product of viral mos oncogene. Nature (1985) 1.85

Use of a new rat chondrosarcoma cell line to delineate a 119-base pair chondrocyte-specific enhancer element and to define active promoter segments in the mouse pro-alpha 1(II) collagen gene. J Biol Chem (1995) 1.85

Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. Proc Natl Acad Sci U S A (2000) 1.82

A sequence conserved in both the chicken and mouse alpha 2(I) collagen promoter contains sites sensitive to S1 nuclease. J Biol Chem (1984) 1.81

Effects of transformation on fibronectin gene expression using cloned fibronectin cDNA. J Biol Chem (1981) 1.79

Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol Cell Biol (1996) 1.78

Coordinate regulation of the levels of type III and type I collagen mRNA in most but not all mouse fibroblasts. J Biol Chem (1985) 1.71

The B subunit of the CAAT-binding factor NFY binds the central segment of the Co-activator p300. J Biol Chem (1999) 1.70

Toward understanding SOX9 function in chondrocyte differentiation. Matrix Biol (1998) 1.70

Tissue-specific expression of the mouse alpha 2(I) collagen promoter. Studies in transgenic mice and in tissue culture cells. J Biol Chem (1992) 1.69

Molecuar model of the DNA interaction site for the cyclic AMP receptor protein. Proc Natl Acad Sci U S A (1981) 1.69

WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases. Mol Cell Biol (1997) 1.68

Mouse type II collagen gene. Complete nucleotide sequence, exon structure, and alternative splicing. J Biol Chem (1991) 1.67

Construction of a recombinant bacterial plasmid containing pro-alpha 1(I) collagen DNA sequences. J Biol Chem (1980) 1.65

Isolation of genomic DNA clones spanning the entire fibronectin gene. Proc Natl Acad Sci U S A (1983) 1.65

An 18-base-pair sequence in the mouse proalpha1(II) collagen gene is sufficient for expression in cartilage and binds nuclear proteins that are selectively expressed in chondrocytes. Mol Cell Biol (1996) 1.64

The B subunit of a rat heteromeric CCAAT-binding transcription factor shows a striking sequence identity with the yeast Hap2 transcription factor. Proc Natl Acad Sci U S A (1990) 1.63

Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer. Mol Cell Biol (2000) 1.63

Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo. J Biol Chem (1998) 1.61

Transcriptional control of the mouse alpha 2(I) collagen gene: functional deletion analysis of the promoter and evidence for cell-specific expression. Mol Cell Biol (1986) 1.60

Construction of a recombinant bacterial plasmid containing a chick pro-alpha2 collagen gene sequence. Proc Natl Acad Sci U S A (1978) 1.59

Determination of functional domains in the C subunit of the CCAAT-binding factor (CBF) necessary for formation of a CBF-DNA complex: CBF-B interacts simultaneously with both the CBF-A and CBF-C subunits to form a heterotrimeric CBF molecule. Mol Cell Biol (1996) 1.56

On the mechanism of action of lac repressor. Nat New Biol (1971) 1.55

Prenatal folic acid treatment suppresses acrania and meroanencephaly in mice mutant for the Cart1 homeobox gene. Nat Genet (1996) 1.54

Stimulation of lac mRNA synthesis by cyclic AMP in cell free extracts of Escherichia coli. Biochem Biophys Res Commun (1970) 1.51

A rapid method for site-specific mutagenesis and directional subcloning by using the polymerase chain reaction to generate recombinant circles. Biotechniques (1990) 1.49

Purification and molecular cloning of the "A" chain of a rat heteromeric CCAAT-binding protein. Sequence identity with the yeast HAP3 transcription factor. J Biol Chem (1990) 1.49

Three classes of mutations in the A subunit of the CCAAT-binding factor CBF delineate functional domains involved in the three-step assembly of the CBF-DNA complex. Mol Cell Biol (1996) 1.49

Sequence rearrangement and duplication of double stranded fibronectin cDNA probably occurring during cDNA synthesis by AMV reverse transcriptase and Escherichia coli DNA polymerase I. Nucleic Acids Res (1980) 1.48

Identification of the promoter and first exon of the mouse alpha 1 (III) collagen gene. J Biol Chem (1985) 1.48

Specificity of the bacteriophage lambda N gene product (pN): nut sequences are necessary and sufficient for antitermination by pN. Cell (1979) 1.47

Separate binding sites for nuclear factor 1 and a CCAAT DNA binding factor in the mouse alpha 2(I) collagen promoter. J Biol Chem (1987) 1.47

Three different polypeptides are necessary for DNA binding of the mammalian heteromeric CCAAT binding factor. J Biol Chem (1992) 1.47

Regulation or procollagen messenger ribonucleic acid levels in Rous sarcoma virus transformed chick embryo fibroblasts. Biochemistry (1981) 1.46

Decreased levels of collagen mRNA in rous sarcoma virus-transformed chick embryo fibroblasts. J Biol Chem (1978) 1.44

Transcription of the chicken alpha 2 (Type I) collagen gene by homologous cell-free extracts. J Biol Chem (1982) 1.44

The 5'-terminal nucleotide sequence of galactose messenger ribonucleic acid of Escherichia coli. Proc Natl Acad Sci U S A (1974) 1.44

Isolation and characterization of genomic DNA coding for alpha 2 type I collagen. Nucleic Acids Res (1980) 1.43

Studies on transcription activation by the multimeric CCAAT-binding factor CBF. J Biol Chem (1995) 1.41

Accurate in vitro transcriptional initiation of the chick alpha 2 (Type I) collagen gene. J Biol Chem (1981) 1.41

Enhanced transfection efficiency and improved cell survival after electroporation of G2/M-synchronized cells and treatment with sodium butyrate. Nucleic Acids Res (1989) 1.40

DNA sequence comparison of the regulatory signals at the 5' end of the mouse and chick alpha 2 type I collagen genes. J Biol Chem (1984) 1.40

Two different negative and one positive regulatory factors interact with a short promoter segment of the alpha 1 (I) collagen gene. J Biol Chem (1990) 1.39

A conserved nucleotide sequence, coding for a segment of the C-propeptide, is found at the same location in different collagen genes. Nucleic Acids Res (1983) 1.37

Developmental and tissue-specific expression directed by the alpha 2 type I collagen promoter in transgenic mice. Proc Natl Acad Sci U S A (1986) 1.34

Expression pattern and gene characterization of asporin. a newly discovered member of the leucine-rich repeat protein family. J Biol Chem (2001) 1.33